Tracy T Ashby

Tracy T Ashby, D.O.

Assistant Professor

Department: Medicine – Jacksonville
Business Phone: (904) 383-1014
Business Email: tracy.ashby@jax.ufl.edu

About Tracy T Ashby

Tracy Ashby, D.O., is a University of Florida assistant professor of medicine and a board-certified pulmonologist and critical care medicine physician at UF Health in Jacksonville. Dr. Ashby received her medical degree from Lincoln Memorial University in Harrogate, Tennessee. She completed her internal medicine residency and pulmonary critical care fellowship at the UF College of Medicine – Jacksonville in Jacksonville, Florida.

Board Certifications

  • Critical Care Medicine
    American Board of Internal Medicine
  • Internal Medicine
    American Board of Internal Medicine
  • Pulmonary Disease
    American Board of Internal Medicine

Clinical Profile

Subspecialties
  • Critical Care Medicine
  • Pulmonary Disease

Publications

Academic Articles
2024
Interstitial Lung Disease as an Emerging Contributor to Mortality in Patients With Inflammatory Bowel Disease: A Population-Based Epidemiological Study.
Clinical and translational gastroenterology. 15(9) [DOI] 10.14309/ctg.0000000000000720. [PMID] 38822801.
2023
Role of COPD in a case of fatal Aspergillus niger tracheobronchitis.
BMJ case reports. 16(3) [DOI] 10.1136/bcr-2022-251807. [PMID] 36948520.
2022
Bacterial pneumonia infection in pregnancy.
Best practice & research. Clinical obstetrics & gynaecology. 85(Pt A):26-33 [DOI] 10.1016/j.bpobgyn.2022.07.001. [PMID] 35970746.
2022
Congenital Pulmonary Airway Malformation in an Adult Male Presenting With Hemoptysis.
Cureus. 14(1) [DOI] 10.7759/cureus.20862. [PMID] 35145769.
2020
Patient-related factors may influence nursing perception of sleep in the Intensive Care Unit.
PloS one. 15(1) [DOI] 10.1371/journal.pone.0226323. [PMID] 31905204.
2018
Toxic epidermal necrolysis after ivermectin.
The American journal of emergency medicine. 36(5):887-889 [DOI] 10.1016/j.ajem.2017.09.021. [PMID] 28927997.

Grants

Feb 2024 ACTIVE
A Phase III, Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA)
Role: Principal Investigator
Funding: ASTRAZENECA PHARM
Jan 2022 – Sep 2023
A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE LONG-TERM SAFETY AND EFFICACY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)
Role: Principal Investigator
Funding: FORTREA via GENENTECH INC
Oct 2021 – Sep 2023
A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
Role: Principal Investigator
Funding: GENENTECH INC

Education

Pulmonary and Critical Care Medicine Fellowship
2016-2019 · University of Florida College of Medicine – Jacksonville, Jacksonville, FL
Internal Medicine Residency
2012-2015 · University of Florida College of Medicine – Jacksonville, Jacksonville, FL
Medical Degree
2008-2012 · Lincoln Memorial University, Harrogate, TN

Contact Details

Phones:
Business:
(904) 383-1014
Emails:
Addresses:
Business Mailing:
655 W 8TH ST
655 W 8TH ST
JACKSONVILLE FL 32209
Business Street:
655 W 8TH ST
JACKSONVILLE FL 32209